SAN FRANCISCO Life sciences company Illumina Inc. is bringing on Charles Dadswell as its new general counsel, replacing the retiring Christian Cabou, who had been with the company since 2006.
Dadswell has been a longtime in-house lawyer in the life science and pharmaceutical fields, most recently as global director of IP and GC of the North American arm of French diagnostics company bioMerieux. He was GC of pharmaceutical company BioDelivery Sciences International Inc. from 2008 to 2011. Prior to that, Dadswell spent 14 years in various legal roles at the British pharmaceutical giant GlaxoSmithKline Plc.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
